Current Issue - March 2013, Volume 7, Issue No. 1

1. Fahey M, Spanier S, Vander Griend R. Osteosarcoma of the pelvis. A clinical and histopathological study of twenty-five patients. J Bone Joint Surg Am. 1992; 74(3): 321-30.
2. Unni KK. Dahlin's bone tumors: general aspects and data on 11,087 cases. 5th ed. Philadelphia, New York: Lippincott-Raven; 1996.
3. Isakoff MS, Barkauskas DA, Ebb D, Morris C, Letson GD. Poor survival for osteosarcoma of the pelvis: a report from the Children's Oncology Group. Clin Orthop Relat Res. 2012; 470(7): 2007-13.
4. Ham SJ, Kroon HM, Koops HS, Hoekstra HJ. Osteosarcoma of the pelvis--oncological results of 40 patients registered by The Netherlands Committee on Bone Tumours. Eur J Surg Oncol. 2000; 26(1): 53-60.
5. Kawai A, Huvos AG, Meyers PA, Healey JH. Osteosarcoma of the Pelvis: Oncologic Results of 40 Patients. Clin Orthop Relat Res. 1998; 348:196-207.
6. Donati D, Giacomini S, Gozzi E, Ferrari S, Sangiorgi L, Tienghi A, et al. Osteosarcoma of the pelvis. Eur J Surg Oncol. 2004; 30(3): 332-40.
7. Saab R, Rao BN, Rodriguez-Galindo C, Billups CA, Fortenberry TN, Daw NC. Osteosarcoma of the pelvis in children and young adults: the St. Jude Children's Research Hospital experience. Cancer. 2005; 103(7): 1468-74.
8. Grimer RJ, Carter SR, Tillman RM, Spooner D, Mangham DC, Kabukcuoglu Y. Osteosarcoma of the pelvis. J Bone Joint Surg Br. 1999; 81-B(5): 796-802.
9. Bielack SS, Wulff B, Delling G, Gobel U, Kotz R, Ritter J, et al. Osteosarcoma of the trunk treated by multimodal therapy: experience of the Cooperative Osteosarcoma study group (COSS). Med Pediatr Oncol. 1995; 24(1): 6-12.
10. Renard AJ, Veth RP, Schreuder HW, Pruszczynski M, Bokkerink JP, van Hoesel QG, et al. Osteosarcoma: oncologic and functional results. A single institutional report covering 22 years. J Surg Oncol. 1999; 72(3):124-9.
11. Enneking WF, Dunham WK. Resection and reconstruction for primary neoplasms involving the innominate bone. J Bone Joint Surg Am. 1978; 60(6): 731-46.
12. Moon SH, Shin KH, Suh JS, Yang WI, Noh JK, Hahn SB. Tumor volume change after chemotheraphy as a predictive factor of disease free survival for osteosarcoma. Yonsei Med J. 2005; 46(1): 119-24.
13. Bieling P, Rehan N, Winkler P, Helmke K, Maas R, Fuchs N, et al. Tumor size and prognosis in aggressively treated osteosarcoma. J Clin Oncol. 1996; 14(3): 848-58.
14. Abudu A, Davies AM, Pynsent PB, Mangham DC, Tillman RM, Carter SR, et al. Tumour volume as a predictor of necrosis after chemotherapy in Ewing's sarcoma. J Bone Joint Surg Br. 1999; 81-B(2): 317-22.
15. Enneking WF, Dunham W, Gebhardt MC, Malawar M, Pritchard DJ. A system for the functional evaluation of reconstructive procedures after surgical treatment of tumors of the musculoskeletal system. Clin Orthop Relat Res. 1993; 286: 241-6.
16. Senchenkov A, Moran S, Petty P, Knoetgen J, Clay R, Bite U, et al. Predictors of Complications and Outcomes of External Hemipelvectomy Wounds: Account of 160 Consecutive Cases. Ann Surg Oncology. 2008; 15(1): 355-63.
17. Ozaki T, Flege S, Kevric M, Lindner N, Maas R, Delling Gn, et al. Osteosarcoma of the Pelvis: Experience of the Cooperative Osteosarcoma Study Group. J Clin Oncol. 2003; 21(2): 334-41.
18. Fuchs B, Hoekzema N, Larson DR, Inwards CY, Sim FH. Osteosarcoma of the Pelvis. Outcome Analysis of Surgical Treatment. Clin Orthop Relat Res. 2009(467): 510-8.
19. Matsuo T, Sugita T, Sato K, Hotta T, Tsuchiya H, Shimose S, et al. Clinical Outcomes of 54 Pelvic Osteosarcomas Registered by Japanese Musculoskeletal Oncology Group. Oncology. 2005; 68(4-6): 375-81.
20. Munajat I, Zulmi W, Norazman MZ, Wan Faisham WI. Tumour volume and lung metastasis in patients with osteosarcoma. J Orthop Surg (Hong Kong). 2008; 16(2): 182-5.
21. Enneking W, Dunham W. Resection and reconstruction for primary neoplasms involving the innominate bone. J Bone Joint Surg Am. 1978; 60(6): 731-46.
22. Bielack SS, Kempf-Bielack B, Delling Gn, Exner GU, Flege S, Helmke K, et al. Prognostic Factors in High-Grade Osteosarcoma of the Extremities or Trunk: An Analysis of 1,702 Patients Treated on Neoadjuvant Cooperative Osteosarcoma Study Group Protocols. J Clin Oncol. 2002; 20(3): 776-90.
23. Shin KH, Moon SH, Suh JS, Yang WI. Tumor volume change as a predictor of chemotherapeutic response in osteosarcoma. Clin Orthop Relat Res. 2000(376): 200-8.
24. Kawai A, Healey JH, Boland PJ, Lin PP, Huvos AG, Meyers PA. Prognostic factors for patients with sarcomas of the pelvic bones. Cancer. 1998 82(5): 851-9.
25. Omololu B, Ogunlade SO, Alonge TO. The complications seen from the treatment by traditional bonesetters. West Afr J Med. 2002; 21(4): 335-7.
26. Bickels J, Kahanovitz N, Rubert CK, Henshaw RM, Moss DP, Meller I, et al. Extraspinal bone and soft-tissue tumors as a cause of sciatica. Clinical diagnosis and recommendations: analysis of 32 cases. Spine (Phila Pa 1976). 1999; 24(15): 1611-6.
27. Thompson RC, Jr., Berg TL. Primary bone tumors of the pelvis presenting as spinal disease. Orthopedics. 1996; 19(12): 1011-6.
28. Kleiner JB, Donaldson WF, 3rd, Curd JG, Thorne RP. Extraspinal causes of lumbosacral radiculopathy. J Bone Joint Surg Am. 1991; 73(6): 817-21.
29. Wurtz LD, Peabody TD, Simon MA. Delay in the Diagnosis and Treatment of Primary Bone Sarcoma of the Pelvis. J Bone Joint Surg Am. 1999; 81(3): 317-25.
30. Faisham WI, Zulmi W, Halim AS, Biswal BM, Mutum SS. Osteosarcoma: the outcome of limb salvage surgery. Med J Malaysia. 2004; 59 Suppl F: 24-34.
31. Rosen G, Caparros B, Huvos AG, Kosloff C, Nirenberg A, Cacavio A, et al. Preoperative chemotherapy for osteogenic sarcoma: Selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy. Cancer. 1982; 49(6): 1221-30.
32. Bramwell VHC, Burgers MV, Souhami RL, Taminiau AHM, Eijken JWVD, Craft AW, et al. A randomized comparison of two short intensive chemotherapy regimens in children and young adults with osteosarcoma: results in patients with metastases: a study of the European Osteosarcoma Intergroup. Sarcoma. 1997; 1(3/4): 155.
33. Souhami RL, Craft AW, Van der Eijken JW, Nooij M, Spooner D, Bramwell VH, et al. Randomised trial of two regimens of chemotherapy in operable osteosarcoma: a study of the European Osteosarcoma Intergroup. Lancet. 1997; 350(9082): 911-7.
34. Bajpai J, Puri A, Shah K, Susan D, Jambhekar N, Rekhi B, et al. Chemotherapy compliance in patients with osteosarcoma. Pediatr Blood Cancer. 2013; 60(1): 41-4.
35. Daw NC, Neel MD, Rao BN, Billups CA, Wu J, Jenkins JJ, et al. Frontline treatment of localized osteosarcoma without methotrexate. Cancer. 2011; 117(12): 2770-8.
36. Cartiaux O, Docquier P-L, Paul L, Francq BG, Cornu OH, Delloye C, et al. Surgical inaccuracy of tumor resection and reconstruction within the pelvis: An experimental study. Acta Orthop. 2008; 79(5): 695-702.

Abstract   |   Reference